Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.

Michael J DiStefano,So-Yeon Kang, Sonal Parasrampuria, Gerard F Anderson

JAMA health forum（2023）

引用 0|浏览5

暂无评分

摘要

This cohort study demonstrated that the $2000 out-of-pocket cap included in the Inflation Reduction Act may substantially moderate the potential increase in spending faced by individuals who use ultra-expensive drugs when moving from commercial insurance to Part D coverage.

查看译文

关键词

commercial insurance,drugs,out-of-pocket,ultra-expensive

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要